Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / David Platt
Person

David Platt

Tracked across 3 events · 38 articles · First seen Jan 29, 2026 · Last active Feb 18, 2026

Sentiment
33
Attention
4
Events
3
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (3)
2 30
Business
Bioxytran and Khoury Medical A-SUQAR Distribution
As CEO of Bioxytran, David Platt views this agreement as an important milestone for the company, signifying a transition to recurring commercial revenue and validating their galectin platform.
Feb 17, 2026 · 7 articles
2 10
Business
Bioxytran and University of Minnesota Research Agreement
David Platt, CEO of Bioxytran, highlighted the importance of the collaboration with the University of Minnesota in strengthening the scientific foundation of Bioxytran's carbohydrate-based technology platform.
Jan 30, 2026 · 12 articles
4 60
Tech
Bioxytran ProLectin-M Phase 2 Success
Dr. Platt, associated with Bioxytran, emphasized Bioxytran===ProLectin-M's novel extracellular mechanism of action, distinguishing it as a broad-range antiviral drug. His insights underscore the scientific innovation behind the therapeutic.
Jan 29, 2026 · 19 articles
Relationships (1)
Bioxytran Company Contact ↔ David Platt David Platt is a company contact for Bioxytran.
NEWSDESK
Track David Platt live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.